Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3390/ijms22063004 http://scihub22266oqcxt.onion/10.3390/ijms22063004 33809421!7998826!33809421     free     free     free Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Int+J+Mol+Sci 2021 ; 22 (6): ä Nephropedia Template TP {{tp|p=33809421|t=2021. Fecal Microbiota Transplantation during and Post-COVID-19 Pandemic |pdf=|usr=}}{{33809421}} gab.com Text Fecal Microbiota Transplantation during and Post-COVID-19 Pandemic JO: Int J Mol Sci http://www.kidney.de/pget.php?&tw=1&pmid=33809421 #FOAvip COVID-19 is a major pandemic facing the world today, which has implications on current microbiome-based treatments such as fecal microbiota transplantation (FMT) used for recurrent Clostridioides difficile infections. The bidirectional relationship between the inhabitants of our gut, the gut microbiota, and COVID-19 pathogenesis, as well as the underlying mechanism involved, must be elucidated in order to increase FMT safety and efficacy. In this perspective, we discuss the crucial cross-talk between the gut microbiota and the lungs, known as the gut-lung axis, during COVID-19 infection, as well as the putative effect of these microorganisms and their functional activity (i.e., short chain fatty acids and bile acids) on FMT treatment. In addition, we highlight the urgent need to investigate the possible impact of COVID-19 on FMT safety and efficacy, as well as instilling stringent screening protocols of donors and recipients during COVID-19 and post-COVID-19 pandemic to produce a cohesive and optimized FMT treatment plan across all centers and in all countries across the globe. Twit Text FOAVip Fecal Microbiota Transplantation during and Post-COVID-19 Pandemic ????Int J Mol Sci http://www.kidney.de/pget.php?&tw=1&pmid=33809421 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33809421 #FOAvip English Wikipedia <ref>{{Cite pmid|33809421}}</ref> Fecal Microbiota Transplantation during and Post-COVID-19 Pandemic #MMPMID33809421 Kazemian N; Kao D; Pakpour S Int J Mol Sci 2021[Mar]; 22 (6): ä PMID33809421show ga COVID-19 is a major pandemic facing the world today, which has implications on current microbiome-based treatments such as fecal microbiota transplantation (FMT) used for recurrent Clostridioides difficile infections. The bidirectional relationship between the inhabitants of our gut, the gut microbiota, and COVID-19 pathogenesis, as well as the underlying mechanism involved, must be elucidated in order to increase FMT safety and efficacy. In this perspective, we discuss the crucial cross-talk between the gut microbiota and the lungs, known as the gut-lung axis, during COVID-19 infection, as well as the putative effect of these microorganisms and their functional activity (i.e., short chain fatty acids and bile acids) on FMT treatment. In addition, we highlight the urgent need to investigate the possible impact of COVID-19 on FMT safety and efficacy, as well as instilling stringent screening protocols of donors and recipients during COVID-19 and post-COVID-19 pandemic to produce a cohesive and optimized FMT treatment plan across all centers and in all countries across the globe. |*Pandemics[MESH] |COVID-19/*epidemiology[MESH] |Clostridium Infections/therapy[MESH] |Fecal Microbiota Transplantation/adverse effects/*methods[MESH] |Gastrointestinal Microbiome[MESH] |Humans[MESH] |Lung/physiopathology[MESH]Fecal Microbiota Transplantation during and Post-COVID-19 Pandemic (epmc).pdf DeepDyve Pubget Overpricing